Herry
et al.’s paper from this week very much stood out to me for its complex detail
and interesting approach. I found that this paper may have been easier for me
to read than other papers used previously since I have become familiar with the
drugs (ie. muscimol) and now that we have been talking about the physiological
methods in more depth. I think that with the mix of pharmacological
activations/ inactivations with electrophysiological recordings I tend to
understand and agree with the findings more, and this one is not very
different. The paper mostly explained the sufficiency and necessity of the BA
and discovering the specificity of onset of physiological change vs phenotypic
expression of behavior which I thought was on one side, expected, but on another,
a very interesting discovery. What I was interested in most was the
change-point point paradigm and the applications for the future of that. The
idea that we are able to find markers of extinction before extinction happens
made me question the potential other experiments that could follow- but I will
revisit that idea after discussing Reznikov et al.
With
Reznikov, something that I’ve noticed with the Journal of Psychiatric Research
is the “short but sweet” nature of the papers. Easily read, this paper is short
yet packed and very easily understood. What I appreciated with this paper, like
Herry et al.’s paper is the future applications brought up by the authors.
Regarding figure 5, I was very interested with the fact that the
weak-extinction group had significantly lower plasma corticosterone levels even
before any fear conditioning. Immediately I began thinking of the possibilities
of early intervention with something like optogenetics and the comparison
between early adolescence intervention of higher coricosterone and later in
life intervention. I wondered if there would be any difference between the more
juvenile rats being exposed to corticosterone and how their extinction would
differ especially since in early life stress there is a tendency for negative
effects to happen when there is high level of stress hormone in the body.
Keeping
with the optogenetic interventions, I think it would also be interesting to see
how changing the change-point neuronal activity would change the outcomes,
perhaps inducing earlier but more robust changes to the activity.
No comments:
Post a Comment